Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Alligator Bioscience Ab

Clinical trials sponsored by Alligator Bioscience Ab, explained in plain language.

Alligator Bioscience AB ATORX NASDAQ STOCKHOLM

Biotech developing antibody-based immunotherapies for cancer.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1

New hope for pancreatic cancer: drug combo shows promise in early trial

Disease control Ongoing

This study tests a new drug called mitazalimab combined with standard chemotherapy for people with metastatic pancreatic cancer that has spread. The goal is to see if the combination is safe and can shrink tumors. About 94 adults who have not had prior chemotherapy for this cance…

Phase: PHASE1, PHASE2 • Sponsor: Alligator Bioscience AB • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC